BACKGROUND: The aim of this research is to verify whether there is evidence in the literature regarding the decrease in viral load present in saliva after using three types of mouthwashes. MATERIAL AND METHODS: Clinical and/or in vitro experimental studies that have used mouthwashes as a form of intervention to reduce the viral load in saliva were included. Combinations of words and appropriate truncations were adapted for each of the seven selected electronic bases including grey literature. RESULTS: The selection of articles was carried out in two phases by two independent reviewers. After removing duplicate articles, 1245 references were maintained, and 2 articles were included in the Systematic Review. Both studies were performed in vitro and tested the virucidal action of the PVP-I solution for mouthwash at two different concentrations, 1% without dilution and 7% with 1:30 dilution, on the SARS-CoV and MERS-CoV viruses. Both showed a viral reduction of ≥ 99.99% with 15 s exposure. CONCLUSIONS: Based on the evidence currently available in the literature, PVP-I, at concentrations of 1 and 7%, appears to be the most effective mouthwash for reducing the viral load of COVID-19 present in human saliva. However, the guidelines for dental care refer to the use of hydrogen peroxide but there is insufficient scientific evidence to support this recommendation. Key words:COVID-19, Coronavirus, Mouthwash, Chlorhexidine, Hydrogen Peroxide, PVP-I. Copyright:
BACKGROUND: The aim of this research is to verify whether there is evidence in the literature regarding the decrease in viral load present in saliva after using three types of mouthwashes. MATERIAL AND METHODS: Clinical and/or in vitro experimental studies that have used mouthwashes as a form of intervention to reduce the viral load in saliva were included. Combinations of words and appropriate truncations were adapted for each of the seven selected electronic bases including grey literature. RESULTS: The selection of articles was carried out in two phases by two independent reviewers. After removing duplicate articles, 1245 references were maintained, and 2 articles were included in the Systematic Review. Both studies were performed in vitro and tested the virucidal action of the PVP-I solution for mouthwash at two different concentrations, 1% without dilution and 7% with 1:30 dilution, on the SARS-CoV and MERS-CoV viruses. Both showed a viral reduction of ≥ 99.99% with 15 s exposure. CONCLUSIONS: Based on the evidence currently available in the literature, PVP-I, at concentrations of 1 and 7%, appears to be the most effective mouthwash for reducing the viral load of COVID-19 present in human saliva. However, the guidelines for dental care refer to the use of hydrogen peroxide but there is insufficient scientific evidence to support this recommendation. Key words:COVID-19, Coronavirus, Mouthwash, Chlorhexidine, Hydrogen Peroxide, PVP-I. Copyright:
Authors: Arturo A Caruso; Antonio Del Prete; Antonio I Lazzarino; Roberto Capaldi; Lucia Grumetto Journal: Infect Control Hosp Epidemiol Date: 2020-04-22 Impact factor: 3.254
Authors: Florence Carrouel; Maria Pia Conte; Julian Fisher; Lucio Souza Gonçalves; Claude Dussart; Juan Carlos Llodra; Denis Bourgeois Journal: J Clin Med Date: 2020-04-15 Impact factor: 4.241
Authors: Gianrico Spagnuolo; Danila De Vito; Sandro Rengo; Marco Tatullo Journal: Int J Environ Res Public Health Date: 2020-03-22 Impact factor: 3.390
Authors: Jhon Paul Iakov Mezarina Mendoza; Briggitte Patricia Trelles Ubillús; Gabriela Tazziana Salcedo Bolívar; Rosa Del Pilar Castañeda Palacios; Paulo Sergio Gilmar Herrera Lopez; David Alex Padilla Rodríguez; Karin Harumi Uchima Koecklin Journal: Saudi Dent J Date: 2022-02-01
Authors: Arturo Cervantes Trejo; Isaac D Castañeda; Alejandra Cortés Rodríguez; Victor R Andrade Carmona; M Del Pilar Calva Mercado; Liliana Salgado Vale; Montserrat Cruz; Sara Barrero Castillero; Lucero Chavez Consuelo; Mauricio Di Silvio Journal: Evid Based Complement Alternat Med Date: 2021-07-03 Impact factor: 2.629
Authors: Alvaro Garcia-Sanchez; Juan-Francisco Peña-Cardelles; Steve Ruiz; Flor Robles; Esther Ordonez-Fernandez; Angel-Orión Salgado-Peralvo; James Balloch; Jacob C Simon Journal: J Clin Med Date: 2022-03-18 Impact factor: 4.241